LYEL Sale Disclosure
Shook David · SEC Form 4 · Filed Sep 10, 2026
Sale
Calculated transaction value
$6.35K
Shook David Chief Medical Officer
LYEL
Lyell Immunopharma
LYEL
Transaction date
Sep 10, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed same day
LYEL daily price context
Close on/before transaction
$12.2
Sep 10, 2026
Close before public filing
$12.88
Sep 9, 2026
Return since public filing
-7.14%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 500 shares @ $12.7
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001959742-26-000003
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$6.35K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Sale | Sep 10, 2026 | $6.35K |